SOLIGENIX INC. news, videos and press releases
For more news please use our advanced search feature.
SOLIGENIX INC. - More news...
SOLIGENIX INC. - More news...
- Soligenix, Inc. to Present at the virtual Fall Investor Summit on November 16th-18th
- Soligenix, Inc. Impresses With Statistically Significant Topline Phase 3 Data From SGX301 FLASH Trial; Targets $250 Million CTCL Patient Market
- Independent Case Study For Soligenix's CTCL Drug, SGX301, Drives Bullish Sentiment; Topline "FLASH" Trial Data Expected Q1 2020
- Soligenix Stock Jumps 95% YTD Ahead of Topline Data Release For SGX301; Targeting $250 Million Unmet Market Opportunity To Treat CTCL
- Catalyst Watch: Soligenix Inc.'s SGX301 and SGX942 Upcoming Data Release Can Change the CTCL and Oral Mucositis Treatment Landscape
- Soligenix's SGX942 On Track To Fill Unmet Medical Need; Targeting Oral Mucositis In Patients With Head and Neck Cancer
- Soligenix to Present at The MicroCap Conference on October 24-25 in Philadelphia